Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

Fig. 2

A Methods used for incidence rates of ARI, SARI and deaths in South Africa. B Estimates of RSV-associated ARI and SARI rates per 100,000 person-years in South Africa by age group and medical status. Error bars show 95% CI values. ARI rates shown are before applying the adjustment described in the “Methods” section that aligns the South African ILI rates with the ARI definition

Back to article page